Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the ...

Novo Nordisk's Victoza (liraglutide) has become the only approved diabetes drug in the GLP-1 agonist class shown to demonstrate a cardiac safety benefit, although it faces competition from a ...

the liraglutide-based Victoza. Exactly why the drug results in fewer opioid deaths isn't clear, the researchers admitted, ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks ... (Trulicity), and liraglutide (Victoza). The study was a kind of review: Researchers ...

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.